Anti-OTOR/ FDP/ MIAL1 functional antibody

Anti-OTOR/ FDP/ MIAL1 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to OTOR/OTOR products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0392-Ab-1/ GM-Tg-hg-SE0392-Ab-2Anti-Human OTOR monoclonal antibodyHuman
GM-Tg-rg-SE0392-Ab-1/ GM-Tg-rg-SE0392-Ab-2Anti-Rat OTOR monoclonal antibodyRat
GM-Tg-mg-SE0392-Ab-1/ GM-Tg-mg-SE0392-Ab-2Anti-Mouse OTOR monoclonal antibodyMouse
GM-Tg-cynog-SE0392-Ab-1/ GM-Tg-cynog-SE0392-Ab-2Anti-Cynomolgus/ Rhesus macaque OTOR monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0392-Ab-1/ GM-Tg-felg-SE0392-Ab-2Anti-Feline OTOR monoclonal antibodyFeline
GM-Tg-cang-SE0392-Ab-1/ GM-Tg-cang-SE0392-Ab-2Anti-Canine OTOR monoclonal antibodyCanine
GM-Tg-bovg-SE0392-Ab-1/ GM-Tg-bovg-SE0392-Ab-2Anti-Bovine OTOR monoclonal antibodyBovine
GM-Tg-equg-SE0392-Ab-1/ GM-Tg-equg-SE0392-Ab-2Anti-Equine OTOR monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0392-Ab-1/ GM-Tg-hg-SE0392-Ab-2; GM-Tg-rg-SE0392-Ab-1/ GM-Tg-rg-SE0392-Ab-2;
GM-Tg-mg-SE0392-Ab-1/ GM-Tg-mg-SE0392-Ab-2; GM-Tg-cynog-SE0392-Ab-1/ GM-Tg-cynog-SE0392-Ab-2;
GM-Tg-felg-SE0392-Ab-1/ GM-Tg-felg-SE0392-Ab-2; GM-Tg-cang-SE0392-Ab-1/ GM-Tg-cang-SE0392-Ab-2;
GM-Tg-bovg-SE0392-Ab-1/ GM-Tg-bovg-SE0392-Ab-2; GM-Tg-equg-SE0392-Ab-1/ GM-Tg-equg-SE0392-Ab-2
Products NameAnti-OTOR monoclonal antibody
Formatmab
Target NameOTOR
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-OTOR benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0392-Ag-1Recombinant multi-species OTOR/ FDP/ MIAL1 protein
    ORF Viral VectorpGMLPm004524mouse Otor Lentivirus plasmid
    ORF Viral VectorvGMLPm004524mouse Otor Lentivirus particle


    Target information

    Target IDGM-SE0392
    Target NameOTOR
    Gene ID56914,57329,366206,695505,100856431,101097883,613456,100062839
    Gene Symbol and SynonymsCDRAP,FDP,MIA,MIAL,MIAL1,OTOR
    Uniprot AccessionQ9NRC9
    Uniprot Entry NameOTOR_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000125879
    Target ClassificationN/A

    The target: OTOR, gene name: OTOR, also named as FDP, MIAL1. This gene encodes a member of the melanoma-inhibiting activity gene family. The encoded protein is secreted via the Golgi apparatus and may function in cartilage development and maintenance. A frequent polymorphism in the translation start codon of this gene can abolish translation and may be associated with forms of deafness. [provided by RefSeq, Jul 2013].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.